Electric cars as batteries
Bidirectional charging has been possible on a technical level for a long…
Athira Pharma Announces Reverse Stock Split
BOTHELL, Wash., Sept. 11, 2025 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (“Athira”…
Lamborghini Polo Storico: old but gold
Every project is a journey through time that restores cars of the…
Skechers Named Top Company by Newsweek and Time Magazines
LOS ANGELES--(BUSINESS WIRE)--Skechers has been named a top U.S. and global brand…
HORNBACH Redefines Retail Innovation with Solace’s Real-time, Event-Driven Integration Platform
Leading European DIY retailer capitalizing on faster access to data and reduced…
DBV Technologies Establishes an At-The-Market (ATM) Program on Nasdaq
Châtillon, France, September 5, 2025 DBV Technologies Establishes an At-The-Market (ATM) Program…
Kia America posts highest monthly sales in company history
Kia’s total sales in August reached 83,007 units, up 10.4 percent year-over-yearYear…
VistaJet presents Mid-Autumn Festival mooncake mixology at 45,000 feet
HONG KONG, Sep. 1, 2025 /PRNewswire/ -- Mid-Autumn Festival is a cherished…
NYSE Content advisory: Pre-Market update + S&P 500 Tops 6,500 for First Time
NEW YORK, Aug. 29, 2025 /PRNewswire/ -- The New York Stock Exchange…
Cytokinetics Announces Primary Results from MAPLE-HCM Presented at the European Society of Cardiology Congress 2025 and Published in The New England Journal Of Medicine
Positive Trial Demonstrates Superiority of Aficamten to Standard-of-Care Beta-Blocker Metoprolol Primary Endpoint…